Drug Type Small molecule drug |
Synonyms (6R,7S)-4-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(thiophen-2-enyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Cefoxitin sodium (JAN/USP), Cefoxitin Sodium for Injetion + [10] |
Target |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (18 Oct 1978), |
Regulation- |
Molecular FormulaC16H17N3NaO7S2 |
InChIKeyMRJZOFPLZPTXGN-XMZRARIVSA-N |
CAS Registry33564-30-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00913 | Cefoxitin Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bacterial Infections | CN | 01 Jan 1995 | |
Bone and joint infections | US | 18 Oct 1978 | |
Gynecological infection | US | 18 Oct 1978 | |
Intraabdominal Infections | US | 18 Oct 1978 | |
Lower Respiratory Tract Infections | US | 18 Oct 1978 | |
Sepsis | US | 18 Oct 1978 | |
Skin and skin structure infections | US | 18 Oct 1978 | |
Urinary Tract Infections | US | 18 Oct 1978 |
Not Applicable | 378 | Prophylactic antibiotics (1 g intravenous cefoxitin) | yaswpjwogj(cxtvdxbgmk) = xedcnrxqjm wvbxnvmuqb (lewwqxxege ) View more | Positive | 01 Jan 2024 | ||
Placebo (normal saline) | yaswpjwogj(cxtvdxbgmk) = jocpkdtmzi wvbxnvmuqb (lewwqxxege ) View more | ||||||
Phase 3 | - | 778 | vvcdczzwqk(lucfauimit) = smrbteisar bjmfceigga (raimmdxlry ) | - | 20 Apr 2023 | ||
vvcdczzwqk(lucfauimit) = nnhfyvzpuf bjmfceigga (raimmdxlry ) | |||||||
Not Applicable | 1,552 | ltflfllcyw(zdmubngpzn) = toiocaiuxu zbqspdupfb (dkpxvikeqg, ouxoroflhp - vygkawborp) View more | - | 18 Apr 2023 | |||
Appendectomy (Appendectomy Arm) | ltflfllcyw(zdmubngpzn) = mnicogbfuz zbqspdupfb (dkpxvikeqg, rmxvnulvif - hxihjqjacd) View more |